FeaturesSignalPricingFounders
Log inGet started free
X

Xerys

Venture CapitalActive

Xery is a portfolio management Company specializing in Venture Capital - Biotech, Medtech, Cleantech, Technology

Paris, FranceFounded 2012xerys.com/
15
Investments
1
Exits
$500M
AUM
6.7%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Xerys.

Get started free

Investment Thesis & Strategy

Xerys is a venture capital firm that invests in various stages of companies within the biotech, medtech, cleantech, and technology sectors. They seek to invest in companies with high growth potential across a diverse range of industries.

Investment Activity

Deals per year over the last 1 years

12
2024

Portfolio Companies

Selected investments from their portfolio of 15 companies

A
Aegle Therapeutics
Biotech · Growth, 2024
Active
A
Aegle Therapeutics
Biotech · Growth, 2024
Active
A
Aegle Therapeutics
Biotech · Growth, 2024
Active
A
Aegle Therapeutics
Biotech · Growth, 2024
Active
A
Aegle Therapeutics
Biotech · Growth, 2024
Active
A
Aegle Therapeutics
Biotech · Growth, 2024
Active
A
Aegle Therapeutics
Biotech · Growth, 2024
Active
A
Aegle Therapeutics
Biotech · Growth, 2024
Active
A
Aegle Therapeutics
Biotech · Growth, 2024
Active
A
Aegle Therapeutics
Biotech · Growth, 2024
Active
A
Aegle Therapeutics
Biotech · Growth, 2024
Active
A
Aegle Therapeutics
Biotech · Growth, 2024
Active

Frequently Asked Questions

Xerys focuses on Series A, Series B, Series C+ stage investments.

Related Investors